Navigation Links
Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
Date:8/20/2007

Company Announces Clinical Trial Plans for 4Q07/1Q08

DALLAS, Aug. 20 /PRNewswire-FirstCall/ -- Access Pharmaceuticals, Inc. (OTC Bulletin Board: ACCP) provided today an update on the clinical development plan of ProLindac, its novel DACH platinum polymer prodrug, and announced plans for additional human clinical trials to be initiated in late 2007/ early 2008. The ongoing clinical trial in recurrent ovarian cancer patients, designed to optimize single agent dosing through schedule diversification and dose escalation, is currently successfully completing the enrollment of its third dose cohort.

"The excellent safety profile, especially the lack of neuro- and nephrotoxicity after multiple treatment cycles, makes it possible for us now to submit an amendment to the ongoing trial which will allow us to further and aggressively explore dosing and schedule optimization in a quicker manner," stated Dr. Esteban Cvitkovic, Vice Chairman (Europe) and recently appointed Senior Director Clinical Oncology. "The recurrent ovarian patient population is an increasingly challenging indication from a regulatory standpoint. Therefore we will continue to be careful with patient eligibility in this single agent trial. We have observed a pharmacological effect at what are still sub-toxic doses which leaves room to increase the therapeutic index in this specific indication. Moreover, this will also allow us to implement combination drug trials, the other main path to obtain further clinical evidence, in a variety of indications, of the full potential for this very promising agent."

Access Pharmaceuticals is currently planning ProLindac drug combination trials to be initiated in the fourth quarter of 2007/early 2008. As has been clinically demonstrated with Eloxatin, Sanofi's marketed DACH platinum, ProLindac's antitumor effect is expected to be synergistic when utilized in combination with other reference anti-cancer agents, such as 5-fluorourcil (5FU) or
'/>"/>

SOURCE Access Pharmaceuticals, Inc.

Copyright©2007 PR Newswire.

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. PromegaExpress Expands Easy Access to Products with New Cabinet
2. Access and Somanta Announce Data to be Presented on Angiolix at ASCO Oncology Conference
3. Access Pharmaceuticals Announces Poster Presentations on ProLindac at the American Association for Cancer Research 2007 Annual Meeting
4. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
5. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
8. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
9. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
10. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
11. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...MINGHAM,Ala.andNOIDA,India,Nov.23/PRNewswire-USNew...Birmingham(UAB),andSouthernResearchInstitutetodaya...rcollectiveinnovationandenablingtechnologiesinthea...es.ItisauniqueU.S.-Indiaarbitragedandleveragedpart...etherapiesforpatientsworldwide.AMemorandumofUnders...
(Date:11/23/2009)...ANTA,Nov.23/PRNewswire-FirstCall/-- CryoLife,Inc. ...ndcardiovasculartissueprocessingcompany,announcedt...erJaffray21stAnnualHealthCareConferenceatTheNewYor...on,presidentandchiefexecutiveofficerofCryoLife,Inc...drecentdevelopmentsandhostaquestionandanswersessio...
(Date:11/23/2009)...HVILLE,Tenn.,Nov.23/PRNewswire-FirstCall/-- Cumber...sitivenewtop-lineresultsfromastudyevaluatingthesaf...eatingfeverinhospitalizedburnpatients. ,, Stati...ofreducingfeverinburnpatientsoverthefirst24hoursof...secondorthirddegreeburnscoveringmorethan10percentt...
Breaking Medicine Technology:Jubilant Organosys, UAB and Southern Research Enter Into Drug Discovery Joint Venture 2Jubilant Organosys, UAB and Southern Research Enter Into Drug Discovery Joint Venture 3Jubilant Organosys, UAB and Southern Research Enter Into Drug Discovery Joint Venture 4CryoLife to Present at 21st Annual Piper Jaffray Health Care Conference 2Caldolor(R) (Ibuprofen) Injection Demonstrates Significant Fever Reduction in Hospitalized Burn Patients 2Caldolor(R) (Ibuprofen) Injection Demonstrates Significant Fever Reduction in Hospitalized Burn Patients 3Chemotherapy for breast cancer is associated with disruption of sleep wake rhythm in women 55788 1Chemotherapy for breast cancer is associated with disruption of sleep wake rhythm in women 55788 2Chemotherapy for breast cancer is associated with disruption of sleep wake rhythm in women 55788 3Workplace bullying is associated with sleep disturbances 55786 1Workplace bullying is associated with sleep disturbances 55786 2Workplace bullying is associated with sleep disturbances 55786 3Pump Up The Volume 3A Equinox Releases Exclusive Celebrity Playlists 55785 1Pump Up The Volume 3A Equinox Releases Exclusive Celebrity Playlists 55785 2
(Date:11/23/2009)...-quarters getting chemo deal with insomnia, study ...s) -- Insomnia and sleep disorders affect more tha...motherapy, a rate nearly three times higher than t..., The problem is more common in younger patient...University of Rochester Medical Center researchers...
(Date:11/23/2009)...ealy, first woman to head the agency, said lives c...lthDay News) -- The fallout from last week,s contr... of routine mammogram testing for breast cancer co...nstitutes of Health advising women to ignore the g... them, because unequivocally this will increase th...
(Date:11/23/2009)...rshipswithMinorityBanksin Washington D.C. , ... IntendedtoSpurEconomicGrowthandRevitalization ,...-DaVita,thenation,sleadingproviderofdialysisservic...costiacommunityfora$1millioninvestmentinIndustrial...communities. ,, DaVita,sinvestmentinWashington,...
(Date:11/23/2009)...rshipswithMinorityBanksin Washington D.C. , ...olumbia , S.C. IntendedtoSpurEconomicGrowthandR...USNewswire/--DaVita,thenation,sleadingproviderofdi...nkInitiativedesignedtocreatejobsandspurrevitalizat...mentsinleadingcommunityandminority-ownedbanks.DaVi...
(Date:11/23/2009)...ion Alliance ProgramSupportsFutureLeadersinSTEMF...leat www.Allia n ceS c holars.org ..."Mr.President,youcancountusin.Withourcommunity,fou...apartofEducatetoInnovate,"saidAdolphP.Falcon,Senio...th,afterattendingaWhiteHousemeetingtodaywherePresi...
Breaking Medicine News(10 mins):Health News:Women Should Ignore New Mammogram Guideline, Ex-NIH Chief Says 2Health News:Women Should Ignore New Mammogram Guideline, Ex-NIH Chief Says 3Health News:DaVita Launches Minority Bank Initiative with $1 Million Investment in Industrial Bank of Washington, D.C. to Support Underserved Communities 2Health News:DaVita Launches Minority Bank Initiative with $1 Million Investment in Industrial Bank of Washington, D.C. to Support Underserved Communities 3Health News:DaVita Launches Minority Bank Initiative with $1 Million Investment in Industrial Bank of Washington, D.C. to Support Underserved Communities 4Health News:DaVita Launches Minority Bank Initiative with $5 Million Investment in Underserved Communities Across the Country 2Health News:DaVita Launches Minority Bank Initiative with $5 Million Investment in Underserved Communities Across the Country 3Health News:Alliance Joins President Obama at White House in Commitment to Science, Technology, Engineering, and Math (STEM) Education 2
...re with the development of attention skills, study...News) -- Even if young children aren,t watching th...nd depriving them of developing critical attention...or about 5 percent less time than when there was n...
...E, Mich., July 15 Webahn Inc. announces,the launc...ion --,Capzule.com. This new system makes it affor...h., *(LOGO Link: Send2Press.com/mediaboom/08-0715...any small,physician groups have not switched over ...
...Educational Films Now Available to Parents In Orde...xual Abuse, PORTLAND, Ore., July 15 Recent studi...s to gain access to children. To better,protect ch...ues in order to create a more open atmosphere for,...
... Financial District Office Workers, Ce...'s, are all eagerly awaiting the opening of a... San Francisco (PRWEB) July 15, 2008 -- Dr. Eb...nstruction has been in the tenant improvement busi...
... International Business Consultant Hel...simple strategies in Business, Employee Management...all Businesses. Long concerned and fascinated with...nomies. , Los Angeles, CA...
... July 15, 2008 A long-time microbial inhabitant o...loping asthma, according to a new study among more...nter researchers. Helicobacter pylori , a bacte...re nearly 59 percent less likely to have asthma if...
Other Medicine News:Health News:Background TV Distracts Kids From Play 2Health News:Background TV Distracts Kids From Play 3Health News:Electronic Medical Records Are No Longer Limited to Physicians with Deep Pockets 2Health News:Pedophiles Thrive on Parental Trust 2Health News:Construction Begins on Executive Express Chiropractic at the SF Embarcadero Center 2Health News:The Five Biggest Marketing Mistakes Made By Medical Offices and Small Businesses 2Health News:Stomach bug appears to protect kids from asthma, says NYU study 2Health News:Stomach bug appears to protect kids from asthma, says NYU study 3
...eference laboratory and a worldwide leader in inno...ffers an extensive test menu of highly complex and...hology. Owned by the University of Utah, ARUP Labo...tion's university teaching hospitals and children'...
...eference laboratory and a worldwide leader in inno...ffers an extensive test menu of highly complex and...hology. Owned by the University of Utah, ARUP Labo...tion's university teaching hospitals and children'...
...eference laboratory and a worldwide leader in inno...ffers an extensive test menu of highly complex and...hology. Owned by the University of Utah, ARUP Labo...tion's university teaching hospitals and children'...
...eference laboratory and a worldwide leader in inno...ffers an extensive test menu of highly complex and...hology. Owned by the University of Utah, ARUP Labo...tion's university teaching hospitals and children'...
Medicine Products: